Product Program year 2025 Source: CMS Open Payments

Eves Eus Ultrasound Bronchofibervideoscope

Device Gastroenterology

PDI 04953170399831

Open in the dashboard

General payments

$527,877

448 payments

Research payments

$90,814

8 payments

Through program year 2025, $527,877 in general payments and $90,814 in research payments were reported against Eves Eus Ultrasound Bronchofibervideoscope (Gastroenterology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $256,024 186
2024 General $271,853 262
2024 Research $69,031 5
2023 Research $21,783 3

Breakdown

Who paid General payments · program years 2024–2025
  1. Olympus Corporation of the Americas $274,319 250 payments
  2. Olympus America Inc. $208,509 138 payments
  3. Olympus Latin America, Inc. $39,915 57 payments
  4. Veran Medical Technologies, Inc. $3,930 2 payments
  5. Gyrus ACMI, Inc. $1,204 1 payment
Top recipients General payments · program year 2025
  1. Alexander Chen Pulmonary Disease · Saint Louis, MO $35,834 14% · 26 payments
  2. Momen Wahidi Pulmonary Disease · Chicago, IL $34,088 13% · 23 payments
  3. Southern Ohio Medical Center Teaching hospital · OH $23,980 9% · 1 payment
  4. Robert Kruklitis Critical Care Medicine · Allentown, PA $21,566 8% · 17 payments
  5. Angela Argento Pulmonary Disease · Baltimore, MD $17,341 7% · 19 payments

The top 5 of 30 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pulmonary Disease Internal Medicine $177,322 81% · 20 practitioners
  2. Critical Care Medicine Internal Medicine $40,915 19% · 3 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $176 <1% · 2 practitioners
  4. Internal Medicine $142 <1% · 1 practitioner
  5. Nurse Practitioner $15 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Illinois $51,429 20% · 2 recipients
  2. Ohio $41,585 16% · 3 recipients
  3. Missouri $35,849 14% · 2 recipients
  4. California $25,786 10% · 3 recipients
  5. Pennsylvania $22,466 9% · 2 recipients

The top 5 of 16 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

448 general · 8 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record